Venomics AI raised USD 2.7 million in pre seed financing co led by Speciale Invest and South Park Commons, with Operators Studio participating. The Bengaluru biotechnology startup combines venom biology, artificial intelligence and laboratory screening to identify molecules that could become therapeutic leads. The company spun out of the Indian Institute of Science and is building a molecular dataset called Venom Atlas. The capital will support dataset expansion, screening capabilities and validation work. Primary confirmation was not located, so verification relies on independent original reports from Inc42 and Business Standard. Discovery activity remains early stage and does not establish that any candidate will become a safe or effective medicine.
Venomics AI raises USD 2.7m for venom research
Speciale Invest and South Park Commons co lead the pre seed round

Keep reading
More Funding

BrightAI secures USD 97 million to scale physical AI infrastructure
Smith Point Capital led the investment in sensor based monitoring for essential services.

Dcubed raises EUR 27.2 million to expand space hardware production
Warsaw Equity Group led the oversubscribed Series A plus round for the German manufacturer.

Linq raises USD 90 million to expand AI powered mobile infrastructure
Andreessen Horowitz led the Series B and partner Ben Horowitz joined the board.


